Idrasil Publishes First White Paper On Cannabis Therapy In Over A Decade

C3 International, Inc., manufacturer of Idrasilâ„¢, the first natural cannabis tablet on the market, has published a white paper revisiting the effects of cannabis-based therapy on migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions.

(PRWeb August 20, 2014)

Read the full story at

Leave a reply